There are 35 genetic subtypes of Limb-Girdle Muscular Dystrophy (LGMD). An early diagnosis is critical for appropriate patient surveillance and monitoring. Gene therapy is being explored for the most common LGMD subtypes. Learn about clinical trials for emerging therapies, genetic testing for diagnosis, and recommended referral pathways for patients with LGMD from experts Dr. Carla Zingariello and Dr. Peter Kang.
This site uses cookies. By continuing to use this website, you agree to their use. For details, please check our Privacy Policy.